Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    


Human Vaccine Project, Vanderbilt, Illumina Join Forces to Decode the Human Immunome


 
James Crowe Jr., MD

The Human Vaccines Project and Vanderbilt University Medical Center (VUMC) announced in April that they joined forces with Illumina, Inc., to decipher the human immunome, the genetic underpinnings of the immune system. Illumina will provide the genetic sequencing technologies and expertise required to process the massive amounts of data required to decode the human immunome.

The Human Vaccines Project is a public-private partnership of academic research centers, industry, non-profits and government agencies that aims to decode the human immune system to accelerate development of next-generation vaccines and immunotherapies. A core initiative of the Project is the Human Immunome Program, an internationally led effort by VUMC to determine key principles of how the human immune system prevents and controls disease by illuminating the complete set of genes and molecular structures known as the human immunome.

"By decoding the human immune system, we have the potential to uncover novel diagnostic biomarkers for a wide range of diseases," said James Crowe Jr., MD., director of the Vanderbilt Vaccine Center and lead investigator of the Human Immunome Program. "This will enable the development of highly targeted vaccines and immunotherapies against infectious and non-communicable diseases like AIDS, Alzheimer's, multiple sclerosis and cancer."

Due to its scale and complexity, the human immunome is estimated to be billions of times larger than the human genome. With recent technological advances from biomedical and computational sciences, it is now possible to undertake such a mammoth genetic sequencing and data analysis program.

The launch of the Project's Human Immunome Program was announced in June 2016. The long-term global study, which is coordinated by the Vanderbilt Institute for Clinical and Translational Research, will genetically sequence the receptors from B and T immune cells from individuals varied by age, gender, genetics, geography and disease states. Results will be shared as an open-sourced database to the global scientific community.

"Sequencing the human immunome is the next frontier of genetic medicine. This important collaboration with The Human Vaccines Project and Illumina marks an exciting step in Vanderbilt's distinguished history and leadership in vaccine research and personalized medicine," said Jeff Balser, MD, PhD, president and CEO of VUMC and dean of the Vanderbilt University School of Medicine. "Insights about the genetic underpinnings of the human immune system gained from this study will help guide future generations of biomarker and therapeutic development."

This multi-institutional effort is also supported by the Human Vaccines Project Bioinformatics and Data Management Core, located at the J. Craig Venter Institute and the San Diego Super Computer Center at the University of California, San Diego. The Core will analyze the enormous data sets generated by the effort.

Share:

 

Email Print

 

More Grand Rounds:

 

Schedule a Blood Donation and Get Safety Information with Amazon Alexa

Red Cross launches three new voice skills, enabling users to access common first aid tips, get notifications for major storms, and schedule blood appointments

Read More

Benefitfocus awards Consociate Health industry-wide recognition for transforming the benefits experience for their customers through data accuracy

Illinois-based Third-Party Administrator (TPA) Consociate Health has been recognized on a national stage for excellence in data accuracy, using key analytics to transform the care management experience.

Read More

Emergency Visits Reach All-Time High

Only 4.3 Percent of Emergency Visits Are Considered Nonurgent, New CDC Data Shows

Read More

BlueCare Tennessee Selects Dungan as CFO

BlueCare Tennessee Selects Dungan as CFO

BlueCare TennesseeSM, the Medicaid subsidiary of BlueCross BlueShield of Tennessee, recently named Casey Dungan, MPA, vice president and chief financial officer.

Read More

PYA Adds Three new Principals

PYA has announced three new Principals are joining the Firm in first quarter: Brian Fuller, Kathy Greenlee, and Merle Glasgow.

Read More

Blakely Joins Bradley as Healthcare Associate

Blakely Joins Bradley as Healthcare Associate

In late February, Bradley Arant Boult Cummings LLP announced Derick Blakely has joined the firm's Nashville office as an associate in the Healthcare Practice Group.

Read More

Gresham Smith Expands Healthcare Practice, Welcomes Langlois

Gresham Smith Expands Healthcare Practice, Welcomes Langlois

Nashville-based Gresham Smith has added to the company's healthcare expertise with the addition of Jim Langlois, AIA, LEED AP, as executive vice president for the firm's Healthcare market and Lesa Lorusso as healthcare directorof research and innovation.

Read More

Ascension Saint Thomas Health Announces New Neurosciences Intensive Care Unit

Ascension Saint Thomas Health Announces New Neurosciences Intensive Care Unit

In late February, Ascension Saint Thomas Health announced the opening of their new multidisciplinary Neurosciences Intensive Care Unit located at Saint Thomas West Hospital.

Read More

Price Joins TriStar Women's & Children's as COO

Price Joins TriStar Women's & Children's as COO

TriStar Centennial Medical Center recently welcomed Amber Price, DNP, CNM as chief operating officer for TriStar Centennial Women's Hospital and The Children's Hospital at TriStar Centennial.

Read More

Let's Give Them Something to Talk About!

Awards, Honors, Achievements

Read More

Business Briefs

Nashville-based Cumberland Emerging Technologies (CET) - a joint initiative between Cumberland Pharmaceuticals, Vanderbilt University, LaunchTN, and China's Gloria Pharmaceuticals - recently announced a collaborative agreement with the technology transfer organization for the Medical University of South Carolina (MUSC) Foundation for Research Development to develop new biomedical products.

Read More

Wishes Granted

Cancer Research UK has awarded a 20-million-pound grant (about $26 million US) to a team of international investigators, including Vanderbilt's James Goldenring, MD, PhD, to study inflammation-related cancers.

Read More

TriStar Health Opens OB/GYN Practice with Multiple Offices

Last month, TriStar Health announced the opening of Centennial Women's Group, an OB/GYN physician practice that is fully dedicated to offering women convenient access to high-quality gynecology and reproductive health services, as well as pre-natal care and delivery.

Read More

Mark Your Calendars

Read More

State Considers Raising Age to Purchase Tobacco, Vaping Products

In late February, Tennessee Sen. Shane Reeves (R-Murfreesboro) and Rep. Bob Ramsey (R-Maryville) held a press conference in conjunction with NashvilleHealth to announce sponsorship of legislation to raise the minimum age to purchase tobacco and vaping products to 21 from the current age of 18.

Read More

Tennessee Issues Maternal Mortality Report

Last month, the Tennessee Department of Health issued the first maternal mortality review report, Tennessee Maternal Mortality Review of 2017 Maternal Deaths.

Read More

Researchers Push Forward Frontiers of Vaccine Science

Researchers Push Forward Frontiers of Vaccine Science

Using sophisticated gene sequencing and computing techniques, researchers at Vanderbilt University Medical Center (VUMC) and the San Diego Supercomputer Center have achieved a first-of-its-kind glimpse into how the body's immune system gears up to fight off infection.

Read More

Smith Harris & Carr Now Harris Frazier Government Relations

Smith Harris & Carr Now Harris Frazier Government Relations

Nashville's oldest lobbying firm, Smith Harris & Carr, is now Harris Frazier Government Relations. The firm, originally known as Smith & Johnson, was founded in 1980.

Read More

NAM Installs New Officers

NAM Installs New Officers

On V. Seenu Reddy, MD, has been named president of the Nashville Academy of Medicine for 2019. Reddy is a cardiovascular surgeon with TriStar Centennial Medical Center.

Read More

TriStar Centennial Welcomes Pantin

TriStar Centennial Welcomes Pantin

Last month, TriStar Centennial Medical Center announced the addition of Jeremy Mark Alexander Pantin, MD, FACP to Sarah Cannon Center for Blood Cancer at TriStar Centennial.

Read More

 
 


Tags:
grand rounds, Human Immunome Program, Human Vaccines Project and Vanderbilt University Medical Center, James Crowe Jr., Vanderbilt Vaccine Center
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: